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Abstract 
Fluorinated carbohydrates, where one (or more) fluorine atom(s) have been introduced into a carbohydrate 
structure, typically through deoxyfluorination chemistry, have a wide range of applications in the glycosciences. 
Fluorinated derivatives of galactose, glucose, N-acetylgalactosamine, N-acetylglucosamine, talose, fucose and 
sialic acid have been employed as either donor or acceptor substrates in glycosylation reactions. Fluorinated 
donors can be synthesised by synthetic methods or produced enzymatically from chemically fluorinated sugars. 
The latter process is mediated by enzymes such as kinases, phosphorylases and nucleotidyltransferases. 
Fluorinated donors produced by either method can subsequently be used in glycosylation reactions mediated by 
glycosyltransferases, or phosphorylases yielding fluorinated oligosaccharide or glycoconjugate products. 
Fluorinated acceptor substrates are typically synthesised chemically. Glycosyltransferases are most commonly 
used in conjunction with natural donors to further elaborate fluorinated acceptor substrates. Glycoside 
hydrolases are used with either fluorinated donors or acceptors. The activity of enzymes towards fluorinated 
sugars is often lower than towards the natural sugar substrates irrespective of donor or acceptor. This may be in 
part attributed to elimination of the contribution of the hydroxyl group to the binding of the substrate to 
enzymes. However, in many cases, enzymes still maintain a significant activity, and reactions may be optimised 
where necessary, enabling enzymes to be used more successfully in the production of fluorinated carbohydrates. 
This review describes the current state of the art regarding chemoenzymatic production of fluorinated 
carbohydrates, focusing specifically on examples of the enzymatic production of activated fluorinated donors 





Fluorinated carbohydrates have been employed for a variety of applications in the fields of biochemistry, 
structural biology, cell biology and immunology.1-6  They have found uses as mechanistic probes for kinetic7,8 
and structural studies9 to help understand protein-carbohydrate binding and catalytic mechanisms of enzymes.  
The in-vitro post-translational modification of proteins with fluorinated carbohydrates has been demonstrated 
to be an effective tool to examine the roles of glycans using 19F NMR.2 Additionally, positron emission 
tomography (PET) allows non-invasive and non-destructive in vivo analysis of carbohydrates incorporating 18F 
in biological systems.5 Approaches such as these are advantageous as they allow the specific behaviour of the 
fluorinated species to be analysed without competing signals arising from other components of the biological 
milieu.10,11 Fluorination has also been shown to endow carbohydrate structures with increased resistance 
towards degradative enzymes.12 This inherent stability makes fluorinated carbohydrates attractive components 
for glycoconjugate vaccines.13  
 
Chemo-enzymatic approaches to the synthesis of natural and chemically modified carbohydrates are well 
established. The review of Li, McArthur and Chen14 provides an excellent summary of chemical and enzymatic 
transformations using natural and synthetic sugars. The reviews of Uhrig and Guo et al.15-16 provide overviews 
of synthetic strategies for fluorination of carbohydrates and methods of introducing stereoselective fluorination 
into monosaccharide structures. Enzymatic synthesis of fluorosugars has however not previously been the 
subject of a focussed extensive review. This work therefore focuses on examining the specific enzymes that 
accept fluorinated sugars as donors or acceptors and how such enzymes are employed to affect the 
transformation of larger and more complex carbohydrate structures.  
 
The success of chemoenzymatic synthesis approaches with modified substrates relies upon the ability of the 
enzyme to both recognise and utilise such substrates despite changes in structure.  Fluorine substitution has been 
shown to have only minimal effect on the conformation of sugars,17 and this has been shown to hold true even if 
sugars bear multiple fluorine substituents.18 However, as fluorine atoms function solely as (weak) hydrogen 
bond acceptors and not as a hydrogen bond donors this can influence the hydrogen bond properties of adjacent 




Some enzymes display high substrate specificity. In some cases, even a single hydroxyl to fluorine substitution 
can prevent a sugar from acting as a substrate.21 Others are more tolerant to fluorinated sugars albeit with lower 
catalytic efficiency as discussed later in this article.  Field and co-workers22 suggest that even at low efficiency, 
enzymatic biotransformations can still provide access to biomolecules that would be laborious to prepare via 
chemical synthesis as enzymes become more widely available.   
 
Enzymes which catalyse glycosylation reactions typically require an activated donor such as a sugar-1-
phosphate or sugar nucleotide mono- or diphosphate. The synthesis of fluorinated donor molecules can often 
also be achieved enzymatically, therefore enzymes which are capable of carrying out these conversions to 
achieve the full enzymatic conversion from fluorinated reducing sugar to glycan are also covered.  It must also 
be noted these ‘intermediates’ are often interesting target molecules in their own right as many have been shown 
to be enzymatic inhibitors and have found applications as mechanistic probes.8   
 
This review is organised by fluorinated sugar. For each named sugar, when and as appropriate, the enzymatic 
synthesis of activated sugar donors and their subsequent use in glycosylation reactions is first discussed, 
grouped by enzyme class, followed by glycosylation using the named sugar as acceptor, either as a 
monosaccharide or as part of a larger glycan, again organised by enzyme class. For the purposes of this review 
the nomenclature used for the fluorinated sugar derivatives does not distinguish between deoxy-fluorination and 
fluorination; 6FGal refers to 6-deoxy-6-fluorogalactose, whilst 6FFuc refers to fucose fluorinated at position 6. 
Where there is geminal difluorination, the original sugar name is maintained for clarity. Unless indicated, all 



















Kinases transfer a phosphate group from a high energy donor – typically adenosine triphosphate (ATP) – to the 
anomeric position of a reducing sugar with -selectivity. Galactose kinase (GalK), N-acetylgalactosamine 
kinase (GalNAcK) and N-acetylhexosamine kinase (NahK) transfer phosphate to the 1-position of Gal, GalNAc 
and N-acetylhexoses respectively. Alternatively, hexokinase catalyses the transfer of phosphate to the 6-position 
of hexoses.  This enzyme can be used with a phosphoglucomutase (PGM) which is capable of isomerising the 





Pyrophosphorylase (or nucleotidyltransferase) enzymes transfer nucleotide monophosphate (NMP) to the 
phosphosugar to give the nucleotide diphosphate (NDP) sugar.  The mechanism involves the formation of a 
ternary complex where a nucleotide triphosphate (NTP) and the sugar-1P substrate successively bind into the 
active site.  This allows nucleophilic attack by the anomeric phosphate moiety onto the first nucleotide linked 
phosphate group, which releases pyrophosphate and the sugar nucleotide. 
 
Glycosyltransferases 
Glycosyltransferases form a glycosylic bond between an activated sugar (usually nucleotidyl phosphate sugar) 
donor and a sugar acceptor such as monosaccharide, oligosaccharide or non-sugar molecule. 
Glycosyltransferases are named for the donor sugar they transfer, so a galactosyltransferase (GalT) transfers 
activated galactose onto an acceptor, a sialyltransferase (SiaT) transfers activated sialic acid etc. Generally, 
GalTs utilise a uridine diphosphate (UDP) donor and SiaTs utilise cytosine monophosphate (CMP) -activated 
sialic acids as the sialic acid donor.  
 
Glycoside hydrolases  
As defined in CAZY database (http://www.cazy.org), glycoside hydrolases catalyse hydrolysis of glycosidic 
bonds. Although glycoside hydrolases are naturally degradative enzymes, under certain conditions some 
enzymes in this class can be directed to the synthetic reaction via reverse hydrolysis or transglycosidation.23 
Some glycoside hydrolases (such as the trans-sialidase from Trypanosoma cruzi) are known to have higher 
synthetic activity than hydrolytic activity, with the active site more suitably accommodating a non-water 
nucleophile such as a sugar molecule. Trans-sialidases transfer sialic acid from a donor oligosaccharide 
containing a terminal sialic acid, such as the heavily sialylated glycoprotein fetuin, to another Gal terminated 
acceptor with -(2→3) configuration.24 In synthetic applications, trans-sialidases have been used as an 
alternative to sialyltransferases to introduce sialic acid to carbohydrate structures. 
 
Phosphorylases 
Phosphorylases catalyse the reversible formation of a monosaccharide-1-phosphate from an oligosaccharide and 






Early evidence that deoxyfluorogalactose-1-phosphate sugar derivatives could be synthesised enzymatically 
from the corresponding deoxyfluorogalactopyranose came from work carried out by Kent and Wright.25  In this 
study, they demonstrated the conversion of 6FGal to 6FGal-1P using a yeast-derived galactokinase (GalK) in 
the presence of ATP.  Westwood et al.26 later evidenced that 2FGal, 3FGal and 4FGal could be converted by the 
same enzyme to 2FGal-1P, 3FGal-1P and 4FGal-1P respectively. The results of their kinetic study suggests the 
yeast-derived GalK has lower affinity for the four fluorinated substrates when compared with the natural Gal 
substrate (in the order Gal > 2FGal > 3FGal ≈ 6FGal << 4FGal).  
 
These early findings were later verified by other groups who exploited GalK to synthesise the anomeric 
phosphates 2FGal-1P, 3FGal-1P and 6FGal-1P on a larger scale.21-22, 27 In these studies, a one-pot, two-enzyme 
system was employed, with the anomeric phosphate converted directly to the UDP-sugar by the 
pyrophosphorylase Gal-1P uridyltransferase (GalPUT).   
 
Hayashi et al.21 reported that yeast GalK catalysed the synthesis of 2FGal-1P in preparative quantities from 
2FGal (Scheme 2).  Stereoselective conversion to the -anomer was confirmed by NMR spectroscopy. The 
isolated 2FGal-1P was then converted to UDP-2FGal using GalPUT, coupled with a UDP-Glc regeneration 
cycle, which avoids the requirement for stoichiometric quantities of commercially available but costly UDP-
Glc. The direct synthesis of -UDP-2FGal from 2FGal was also possible without isolating the phosphate 
intermediate.  
 




Enzymatic synthesis of fluorinated nucleotide donors was also demonstrated by Barlow and Blanchard28.  In this 
work, the authors describe the synthesis of both UDP-2FGal and UDP-3FGal from 2FGal and 3FGal 
respectively in preparative scale at near quantitative yields (based upon UDP-Glc conversion).  This study also 
employs an alternative strategy to overcome problems associated with the purification of the desired UDP-sugar 
from the UDP-Glc generated in the catalytic cycle (Scheme 3). By using phosphoglucomutase (PGM) in place 
of UDP-Glc pyrophosphorylase the reaction was driven toward UDP-2FGal. The UDP-Glc cofactor could be 
removed from the system via further enzymatic breakdown, using glucose-6-phosphate dehydrogenase.  This 
system does however require near stoichiometric quantities of costly UDP-Glc.  
 
Scheme 3 Enzymatic synthesis of UDP-2FGal and UDP-3FGal with enzymatic breakdown of UDP-Glc.28 
 
The utility and substrate scope of the GalK/GalPUT two-enzyme system was further expanded by Errey et al.22 
In this work, the authors describe that UDP-6FGal can be synthesised from 6FGal using the GalK/GalPUT 
system (Scheme 4). Under identical reaction conditions, yields of UDP-2FGal were comparable to those 
achieved for the synthesis of UDP-Gal. In both cases near quantitative conversion was observed. In comparison, 
UDP-3FGal (64%) and UDP-6FGal (37%) were isolated in lower yields than the UDP-2FGal and the 
nonfluorinated product. Higher enzyme concentrations and longer reaction times were required for the synthesis 
of both UDP-3FGal and UDP-6FGal than for UDP-Gal and UDP-2FGal.  It was unclear to the authors from 
their one-pot experiments which enzyme was rate limiting, but further experiments using chemically synthesised 
or commercially available sugar-1-phosphates of non-galactose sugars indicated that GalPUT has a relaxed 
substrate specificity and is able to turn over substrates not accepted by the two-enzyme system. This suggests 
GalK to be the rate limiting enzyme in the two-enzyme system. Indeed, these observations correlate with the 
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early kinetic findings presented by Bessell et al.,29 who found GalK to have a greater affinity for 2FGal than 
3FGal and 6FGal.  In addition to using the UDP-Glc regeneration cycle to aid product purification, Errey and 
coworkers22 made use of GalK and GalPUT immobilised onto resin surfaces which offered the additional 
benefits of allowing facile enzyme recovery and simplified purification methods. This approach also meant the 
enzymes could be used in excess, allowing even reactions with low efficiency compared to natural substrates to 
be successfully achieved on a preparative scale. 
 
 
Scheme 4 Enzymatic synthesis of UDP-2FGal UDP-3FGal and UDP-6FGal using immobilised enzymes and the 
UDP-Glc regeneration cycle.22 
 
The synthesis of UDP-4FGal from 4FGal was reported in the 2012 patent application of Nishimura et al. in two 
steps using E. coli derived GalK (EcGalK) and GalPUT (Scheme 5).30  The authors noted that the conversion for 
the second step (i.e. the formation of UDP-4FGal from 4FGal-1P) was 30% lower if using GalPUT from yeast 
instead of E. coli was used, which highlights the value in considering enzymes from different sources.  
Likewise, although initial kinetic studies using yeast GalK indicated a four-fold increase in Km for 4FGal 
relative to Gal and a Vmax of 10% relative to Gal29, the authors reported a surprisingly short reaction time (1 h) 
using E. coli GalK.   
 




6,6-Difluoro-galactose has been shown to be a substrate for GalK from Lactococcus lactis, a GalK demonstrated 
to have good substrate promiscuity against a large panel of sugars, with modifications at the 2, 3, 4 or 6 position 





















Scheme 6 Enzymatic phosphorylation of 6,6-difluoro-galactose.31  
 
A series of furanosyl sugar nucleotides have been synthesised using a bacterial α-D-glucopyranosyl-1-phosphate 
thymidylyltransferase, Cps2L from Streptococcus pneumoniae.32 In these reactions, chemically synthesised 6-
fluoro-galactofuranosyl-1-phosphate (anomeric mixture α/β = 1.7/1) was successfully converted into 
deoxythymidine diphosphogalactofuranose (dTDP-Galf) in the presence of Cps2L, deoxythymidine 5’-
triphosphate, Mg2+ and inorganic pyrophosphatase (Scheme 7). The conversion was moderate, only 19% in a 24 
hour reaction. Later, the authors engineered Cps2L to expand its repertoire of nucleotide substrates including 
uridine and guanidine.33 One of mutants, Cps2L Q24S showed an enhanced activity in the conversion of 6-
fluoro-galactofuranosyl-1-phosphate (α/β = 1.7/1) to dTDP-Galf with a conversion rate of c.a. 30% in 18 hours 
although its intended activity of uridylyltransfer was not detected with 6FGalf (Scheme 7).  
 
 






An understanding of the likely catalytic mechanism for galactosyltransferase enzymes along with metabolic 
studies using 2FGal (which causes inhibition of glycosylation),34 lead Hayashi et al.21 to propose that a strongly 
electron withdrawing fluorine atom at C-2 would result in enzyme inhibition. They report the Ki (14918 M) 
versus Km (1279 M) for UDP-Gal indicating that the affinity of UDP-2FGal for the enzyme is comparable to 
the natural substrate and demonstrate UDP-2FGal to be a competitive inhibitor of -(1→4) galactosyltransferase 
(GalT), with respect to UDP-Gal, fluorine at the 2-position unaffecting binding to the enzyme, but making the 
glycosidic bond inert to cleavage.  
 
Whilst -(1→4) GalT is inhibited by UDP-2FGal, it is capable of processing both the UDP-4FGal and UDP-
6FGal donors.  To the best of our knowledge, there are no published examples UDP-3FGal being used as a 
donor in glycosyltransferase catalysed reactions.   
 
4FGal and its applications, including the synthesis of UDP-4FGal detailed earlier, are reported in the previously 
mentioned 2012 patent application30 in which the use of UDP-4FGal as a donor for human derived -(1→4) 
GalT is described.  Incubation of the enzyme with a variety of -glycosides of GlcNAc, followed by mass 
spectral characterisation indicated the formation of a peak corresponding to the desired disaccharides. However, 








UDP-6FGal (obtained by chemical methods) was shown by Kodama et al. to be a substrate for -(1→4) GalT 
from bovine milk, albeit at rates significantly lower than of UDP-Gal (Scheme 9).35 Nonetheless, increasing the 
enzyme concentration and reaction time allowed the enzyme to transfer UDP-6FGal to the natural GlcNAc 
acceptor to produce the fluorinated LacNAc analogue in 59% yield, with the regio- and stereoselectivity 
confirmed by proton NMR spectroscopy. In an independent study36 using the same enzyme and acceptor, the 
authors were unable to detect transfer of UDP-6FGal to GlcNAc and demonstrated its ability as a competitive 
inhibitor of the enzyme. However, they noted that enzyme concentrations and reaction times were significantly 
reduced compared with the earlier study.  These conflicting observations highlight the importance of screening 
multiple reaction conditions, and show that although reaction rates can be low compared to natural sugars, under 
optimised conditions use of enzymes can be a viable method of synthesis.   
 
Scheme 9 -(1→4) GalT enzymatic synthesis of disaccharides containing 6FGal.35 
 
3.2.2  Phosphorylases 
Galactosyl 1-phosphate donors can be utilised by a phosphorylase from Bifidobacterium infantis 
(BiGalHexNAcP) for the synthesis of -(1→3) linked disaccharides.  Furthermore, the phosphorylase enzyme 
along with a suitable kinase such as EcGalK can be used in a one-pot, two-enzyme system to afford the 
disaccharide directly from the reducing sugar.37  This system has been successfully employed with certain 
monofluorinated sugars. 
 
Enzymatically synthesised 6FGal-1P was shown by Yan et al. to be substrate for BiGalHexNAcP and was able 
to be transferred to the 3-OH of a GalNAc acceptor with -selectivity (Scheme 10).38  Preparative scale yields 
were high (ca. 80%) and comparable to the natural donor Gal-1P.  Furthermore, the enzyme was demonstrated 
to transfer 6FGal-1P to the unnatural fluorinated 6FGalNAc acceptor at yields comparable to GalNAc, yielding 
disaccharide fluorinated in both sugar units (see section 5). BiGalHexNAcP has optimum activity at pH 5.0 to 
6.5, whereas EcGalK has optimum activity at pH >7.0. When using natural donors and acceptors, pH 6.5 was a 
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good compromise giving reasonable overall yields, however for the fluorinated donors and acceptors, to 
maximise yields, a two-step process was used, at pH 7.5 for the kinase reaction, and then once the reaction was 
complete as monitored by TLC, at pH 6.0 with addition of BiGalHexNAcP. 
 
Scheme 10 One-pot two-step disaccharide synthesis using 6FGal.38 
 
Whilst the authors initially reported that 2FGal-1P is not a substrate for the enzyme they later demonstrated that 
it can be transferred to either GalNAc or GlcNAc acceptors.39  As the Bifidobacterium infantis kinase BiGalK 
has relaxed substrate specificity and good activity at pH 6.5 this removed the need for a two-step reaction 
(Scheme 11). Under the same reaction conditions, isolated yields (26-28%) were much lower than for Gal-1P 
and 6FGal-1P however this activity and transformation is important, as 2-fluorinated UDP donors are inhibitors 
of glycosyltransferases as previously described, therefore the enzymatic routes to the synthesis of disaccharides 
containing 2-deoxy-2-fluoro sugar moiety at the reducing end are limited.  Furthermore, it is worthwhile noting 
that in this two-enzyme reaction, the low conversion is due to the phosphorylase enzyme rather than the kinase, 
as 2FGal-1P can be synthesised by both EcGalK and BiGalK in yields greater than 90% under the conditions 





Scheme 11 One-pot disaccharide synthesis using 2FGal.39 
 
3.2.3 Glycoside hydrolases 
As fluorinated carbohydrates have been reported to act as mechanism-based inhibitors of glycoside hydrolases 
particularly as a donor,6, 12 it is not surprising to be able to find only few examples. O’Donohue et al. used p-
nitrophenyl β-D-galactofuranoside (pNP-βGalf) as a substrate of arabinofuranosidase from Thermobacillus 
xylanilyticus (AbfD3) to conduct transglycosidation reaction.40 To avoid extensive hydrolysis, the authors 
stopped the reaction in 30 minutes, and detected two transglycosidation product, β-(12) and β-(13) 
disaccharides, both of which were spectroscopically characterised (Scheme 12). Although the conversion rates 
or yields were not reported, the HPLC chromatogram showed that hydrolysis products were predominant. In 
another example, Ferrieres et al. conducted an enzymatic reaction with arabinofuranosidase (Araf51) from 
Clostridium thermocellum  containing galactosyl furanose derivatives as substrates.41 The original intention was 
to use pNP-βGalf as donor and octyl 6-fluoro-β-D-galactofuranoside (Oct 6FGalf) as acceptor, but the reaction 
yielded a mixture of various length oligosaccharides with both substrates as either donor or acceptor (Scheme 
12). A few oligosaccharide products showed that Oct 6FGalf acted as donor albeit with the yield of only 1 – 6%, 





Scheme 12 Use of arabinofuranosidase to synthesise fluorinated di-galactofuranosides.40-41   
 
3.3  Fluorinated galactose acceptors 
Fluorinated galactose has also been used as an acceptor in enzymatic glycosylation, not as the monosaccharide 
but as a non-reducing galactose moiety as part of a disaccharide or larger oligosaccharide. 
 
3.3.1  Galactosyl‐ and N‐acetylgalactosaminyltransferases 
The disaccharide Fuc--(1→2)Gal is a motif common to both A and B blood group antigens.  In biosynthetic 
pathways, -(1→3) galactosyltransferase (-(1→3)GalT) is responsible for transferring a Gal residue from 
UDP-Gal to this motif to give the B group antigen whereas -(1→3) N-acetylgalactosaminyltransferase (-
(1→3) GalNAcT) transfers a GalNAc residue to give the A antigen.42  Following chemical synthesis of the 
fluorinated acceptor analogue Fuc--(1→2) 6FGal-O(CH2)7CH3, biosynthesis of the modified antigens was 
achieved using both natural donors (Scheme 13),43 however the enzymes -(1→3)GalT and -(1→3)GalNAcT 
had a lower affinity for the fluorinated acceptor than the natural acceptor (-(1→3)GalT 30% activity, -
(1→3)GalNAcT 43% activity relative to the native disaccharide).  Fuc--(1→2)4FGal was not a substrate (or 
inhibitor) for either enzyme, demonstrating the importance of the 4-position hydroxyl for these enzymatic 




Scheme 13 6FGal as acceptor in enzymatic synthesis using galactosyl and N-acetylgalactosamine transferases.43 
 
3.3.2  Sialyltransferases and trans‐sialidases 
Fluorinated sugars have been utilised as acceptor substrates for sialylation using both sialyltransferases (SiaT) 
and trans-sialidases. The enzymatic incorporation of fluorinated sialic acid derivatives as donors is discussed in 
section 9.  
 
The disaccharide 2FGal -(1→3) GalNAc is a suitable acceptor substrate for the -(2→3) Pasteurella 
multocida SiaT 1 (PmST1).  The trisaccharide Neu5Ac -(2→3) 2FGal -(1→3) GalNAc -O-(CH2)3N3 was 
synthesised in preparative scale in excellent yields from the corresponding disaccharide acceptor 2FGal -
(1→3)  GalNAc -O-(CH2)3N3  and Neu5Ac using this enzyme, coupled with the CMP sialic acid synthetase 
from Neisseria meningitidis (NmCSS) in a one-pot, two-enzyme system (Scheme 14).  Yields were comparable 
to the natural acceptor Gal -(1→3) GalNAc under the same reaction conditions.39   
 
Scheme 14 2FGal as acceptor in enzymatic synthesis using SiaT PmST1.39 
 
Incubation of dodecyl 2FGal, dodecyl 4FGal and dodecyl 6FGal with mouse melanoma B16 cells showed 
toxicity with 6FGal and 4FGal, however 2FGal produced a glycosylated product, corresponding to a sialylated 
product by mass spectrometric analysis.44 This observation was confirmed through use of a -(2→3) sialidase 
from S. typhimurium (cloned in E. coli) to be a fluorinated analogue of the ganglioside GM-4 (Neu5Ac -(2→3) 
16 
 




Scheme 15 2FGal as acceptor for cellular -(2→3) SiaT from S. typhimurium.44 
 
Disaccharides terminated with 2FGal have also been shown to be suitable acceptors for the T. cruzi trans-
sialidase (TcTs) mediated transfer of Neu5Ac from the heavily sialylated mammalian protein fetuin. A crude 
cell lysate can be used for the transformation, and using TcTs with fetuin as the Neu5Ac donor removes the 
requirement for CMP-Neu5Ac and the enzymes associated with its synthesis.  Using this system, Allman et al.45 
demonstrated the synthesis of the trisaccharides Neu5Ac -(2→3) 2FGal -(1→4) GlcNAc and Neu5Ac -
(2→3) 2FGal -(1→3) GlcNAc, from the corresponding chemically synthesised disaccharides, with the regio- 
and stereo-selectivity of the enzyme confirmed via NMR spectroscopy (Scheme 16).  For both -(1→3) and -
(1→4) linked disaccharides, yields for the sialylation were less than obtained for the natural disaccharides, 
although in the case of the natural -(1→4) disaccharide, the use of an OBn anomeric protecting group instead 
of OTBDMS at the reducing end could also affect the affinity of the enzyme for the acceptor. 
   
Scheme 16 2FGal as acceptor in enzymatic synthesis using TcTs.45 
 
4FGal -(1→4) GlcNAc -(1→2) Man was shown to be a substrate for both human and recombinant rat liver 
-(2→6) SiaT with a good sialylation rate relative to the natural trisaccharide Gal -(1→4) GlcNAc -(1→2) 
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Man, and also a poor substrate for recombinant rat liver -(2→3) SiaT.46 3FGal -(1→4) GlcNAc -(1→2) 
Man showed low-level sialylation with both the human and rat liver -(2→6) SiaT in screening  reactions 
(Scheme 17). In scale-up synthesis, the fluorinated tetrasaccharides Neu5Ac -(2→3) 4FGal -(1→4) GlcNAc 
-(1→2) Man and Neu5Ac -(2→6) 4FGal -(1→4) GlcNAc -(1→2) Man were able to be synthesised in low 
milligram quantities from 4FGal -(1→4) GlcNAc -(1→2) Man using rat liver recombinant 2-3 SiaT or rat 
liver 2-6 SiaT respectively. Reactions were performed over 7 days with CMP-Neu5Ac added in batches every 
2 days, along with calf intestinal alkaline phosphatase to break down the released CMP, which otherwise 
inhibits the sialyl transferase.47 
  
Scheme 17 Trisaccharides containing 3FGal or 4FGal as acceptors in enzymatic synthesis using -(2→3) and 
-(2→6) SiaTs.46 
 
Rat liver -(2→3) - and -(2→6) - SiaTs also tolerate 4-deoxy-4-fluorogalactoside acceptors with further 
modifications at the reducing end. The Neu5Ac -(2→3) 4FGal and Neu5Ac -(2→6) 4FGal glycosides 
depicted in Scheme 18 were detected via HPLC and mass spectrometry following reaction with the appropriate 
enzyme and CMP-Neu5Ac, however the connectivity was not unambiguously determined.  In all examples, 




Scheme 18 Disaccharide containing 4FGal as acceptor in enzymatic synthesis using -(2→3) and -(2→6) 
SiaTs.30 
 
Completing the fluorinated galactose sugars, disaccharides containing 6FGal were shown to be excellent 
acceptors for the -(2→3) SiaT PmST1 (Scheme 19).  Combined with NmCSS in the one-pot, two-enzyme 
system introduced above, the -(2→3) linked sialosides have been synthesised in milligram quantities, in yields 
comparable to the natural acceptor under the same reaction conditions.  Stereo- and regioselectivity of the 









The synthetic strategy toward deoxyfluoro--D-glucopyranosyl phosphates and UDP-deoxyfluoro--D-
glucopyranoside donors differs from that described above for their galactosyl analogues.  Although GalK 
tolerates the introduction of fluorine, it has a high stringency toward galactose stereochemistry and Westwood 
demonstrated many years ago that 4FGlc was neither a substrate nor an inhibitor of yeast GalK.26  Even a 
mutant GalK, which is known to possess relatively relaxed substrate specificity at the C-4 position was unable 
to efficiently phosphorylate 3FGlc, 4FGlc or 6FGlc.48  Indeed, to the best of our knowledge, no kinases have 
been reported in the literature that are capable of efficiently processing deoxyfluorinated glucopyranosides. 
With the lack of suitable kinases, other enzymes have been evaluated in order to enzymatically access 
deoxyfluoro--D-glucopyranosyl phosphates. In particular, the hexokinase/phosphoglucomutase approach has 
shown promise.  Early kinetic studies revealed 2FGlc and 2,2FFGlc are good substrates for yeast hexokinase 
with affinities similar to Glc.29 A hexokinase/phosphoglucomutase approach, followed by conversion with 
UDP-glucose-1-pyrophosphorylase, has been used in the synthesis of UDP-2FGlc (Scheme 20).11  The UDP-
glucose-1-pyrophosphorylase mediated step was investigated further, and it was found that the activity of this 
enzyme decreases by a factor of 30 for the 2FGlc-1P compared with Glc-1P, and a six-day reaction time was 
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required to achieve 60% conversion of the 2FGlc. Following purification, UDP-2FGlc could be isolated in 
milligram quantities in 38% yield.  The authors then attempted to extend this methodology to the synthesis of 
18F radio-labelled UDP-2FGlc. However, limited radiochemical yields led them to employ a chemo-enzymatic 
protocol whereby the 2FGlc-1P was first synthesised chemically.  Enzymatic conversion to UDP-2FGlc was 
carried out in the void volume of an anion exchange cartridge, and using increased concentrations of UDP-
glucose-1-pyrophosphorylase, the product was isolated with a radiochemical yield of 20% with a total synthesis 




Scheme 20 Enzymatic synthesis of UDF-2FGlc using hexokinase, phosphoglucomutase and UDP-Glc 
pyrophosphorylase.11 
 
On the other hand, 3FGlc and 4FGlc are poor substrates for yeast hexokinase.29  Indeed, the hexokinase/PGM 
approach to synthesising 3FGlc-1P and 4FGlc-1P from 3FGlc and 4FGlc respectively was evaluated by Caputi 
et al. who found only a low conversion to the anomeric phosphates, and abandoned this pathway in favour of 
other more synthetically viable routes.  Namely, they successfully demonstrated the combination of UDP-Gal 
synthesis with uridine-5’-diphosphogalactose-4-epimerase (GalE) for the synthesis of fluorinated UDP-sugars 
with the glucose configuration.  UDP-6FGal was enzymatically synthesised using the GalK/GalPUT system 
described earlier.22 Subsequent incubation with GalE resulted in inversion of the stereochemistry at C-4’ to give 
UDP-6FGlc, with the equilibrium reached after 3 hrs in favour of the glc-configured product (UDP-6FGlc:UDP-
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6FGal 3:1) (Scheme 21).48  The extension to the GalE approach to other members of the deoxyfluoro glucosyl 





The feasibility of UDP-6FGlc as a donor for glucosyltransferase mediated synthesis was demonstrated using the 
oat root transferase SAD10, whose physiological role is the generation of O-glucosyl N-methylanthranilate 
ester.  Indeed, UDP-6FGlc (synthesised from UDP-6FGal by GalE as described earlier)48 was a substrate for the 
SAD10, which transferred the 6FGlc to N-methylanthranilic acid (MNA-H).  The reaction did not proceed to 
completion, but instead an equilibrium was reached within 20 hours, which showed approximately 31% 
conversion of UDP-6FGlc into 6FGlc-NMA.  This ratio was similar for the natural donor UDP-Glc.48   
Certain glycosyltransferases from bacterial sources have been revealed to catalyse their traditional reaction in 
reverse, and this offers an alternative strategy toward the synthesis of NDP-sugars that does not require multiple 
enzymes (e.g. kinases, pyrophosphorylases, phosphatase) described above.  However, careful selection of the 
activated aromatic glycoside donors is required to overcome thermodynamic limitations in order to drive the 
formation of NDP-sugar. Extensive screening of a range of aromatic glycosides and variants of oleandomycin 
glycosyltransferase (OleD) from Streptomyces antibioticus revealed a variant TDP16 and 2-chloro-4-
nitrophenyl--D-glucopyranoside to be the best enzyme/donor combination for the reaction to occur in reverse. 
Furthermore, little to no donor hydrolysis was observed under the conditions.  The authors went on to show 
TDP16 was able to convert 2-chloro-4-nitrophenyl-6-fluoro--D-glucopyranoside to either UDP-6FGlc or TDP-
6FGlc when reacted in a 1:1 molar ratio with UDP or TDP, respectively (Scheme 22).  For both NDPs, the 




Scheme 22 Enzymatic synthesis of UDP- or TDP-6FGlc using the reverse reaction of a glycosyltransferase, 
TDP16, an engineered variant of OleD.49 
 
Further to this, it was shown that TDP16 could be used in a one-pot glycosylation procedure whereby the NDP-
donor produced by the reverse reaction could be coupled in situ to an aglycone acceptor by the same or an 
additional glycosyltransferase working in the forward direction.  Thus, from 2-chloro-4-nitrophenol-6-fluoro--
D-glucopyranoside, the 6F-glucosides of both 4-methylumbelliferone (MBU) and vancomycin were detected 
using either a single enzyme (MBU) or double enzyme (vancomycin) coupled system in the presence of a molar 
equivalent of UDP.  After a reaction time of 24 hours, 70% and 40% conversion from the donor were observed 
for the MBU and vancomycin glycosides respectively.49 
Cps2L (Streptococcus pneumoniae) is the enzyme that catalyses the synthesis of deoxythymidine diphosphate 
glucopyranose (dTDP-Glc), from glucose-1-phosphate.  When evaluated against a panel of fluorinated glucose 
phosphates (2FGlc, 3FGlc, 4FGlc, 6FGlc, 4FGal, and 2,2F2Glc) and 2FMan, it was shown to exhibit broad 
substrate specificity as it could convert all the substrates almost as effectively as for the natural substrate Glc-1P 
within 20-30 minutes (Scheme 23).50 Kinetic analysis revealed 6FGlc behaved in a very similar manner to Glc, 
and this is consistent with previous studies that indicated that the 6’-hydroxyl group of Glc-1P made the 
smallest contribution to interactions with the enzyme51.  Fluorination at the 3’ position resulted in the most 
substantial decrease of kcat/Km compared to Glc-1P and other monofluorinated substrates, and to a somewhat 
lower extent, the enzyme did not tolerate well a change in stereochemistry at the 4 position. The 2,2 
difluorinated version of Glc-1P maintained binding affinity, but with a decreased turnover number.50 The same 
set of fluorinated sugars were evaluated with the enzyme guanosine diphosphate-mannopyranose 
pyrophosphorylase (GDP-ManPP) from Salmonella enterica (Scheme 23).50 When given long enough reaction 
times, the enzyme was capable of turning over all the sugars assayed.  2FGlc-1P, and 2F2FGlc-1P were 
converted almost quantitatively within 2.5 h, which is consistent with the timeframe for the natural substrate 
Man-1P.  3FGlc-1P, 4FGlc-1P, 4FGal-1P and 6FGlc-1P required longer reaction times for similar rates of 
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conversion. The authors suggested the possible use of the enzymes and products in the synthesis of unnatural 

















The use of fluorinated glucose as an acceptor of glycosyltransferases is rare. Notable examples are the synthesis 
of fluorinated trehalose analogues. Trehalose-6-phosphate (T6P) synthase (OtsA) from E. coli is a retaining 
glucosyltransferase that transfers glucose from UDP-glucose to the anomeric centre of glucose-6-phosphate 
(G6P) to synthesise a non-reducing disaccharide phosphate, trehalose-6-phosphate (Scheme 24). 2-Fluoro-, 3-
fluoro- and 4-fluoro-glucose-6-phosphates and 2-fluoro-mannose-6-phosphate were used as the acceptor for 
kinetic studies, which revealed all the fluorinated acceptors acted as a substrate albeit with lower catalytic 
efficiencies.52 Products were not analysed spectroscopically except for 2-fluoro-trehalose-6-phosphate, which 
was fully characterised.53 2-F T6P then undergoes phosphate hydrolysis by T6P specific phosphatase, OtsB to 
yield 2-fluoro-trehalose (Scheme 24). Later, the Swarts group used a trehalose synthase (TreT) from 
Thermoproteus tenax to synthesise fluorinated trehalose analogues.54 This enzyme is a retaining 
glucosyltransferase that uses UDP-glucose as a donor and glucose as acceptor, and thus able to synthesise 
trehalose in one step unlike the OtsA approach. The authors demonstrated that TreT could accept 2-fluoro-, 3-
fluoro- and 6-fluoro-glucose as acceptor substrates while it did not react with 4-fluoro-glucose (Scheme 24). In 
contrast to OtsA, TreT showed comparable activities with fluorinated glucose acceptors to that of glucose, and 
particularly, the highest activity was measured with 2-fluoro-glucose. 2-Fluoro-, 3-fluoro- and 6-fluoro-
trehalose analogues were fully characterised.   
 
Scheme 24 Enzymatic synthesis of 2F-trehalose-6-phosphate using trehalose-6-phosphate synthase (OtsA)53 and 




In some cases, fluorinated glucose analogues have been used as an acceptor of transglycosidation by glycoside 
hydrolases (GHs). As mentioned earlier, synthetic activities of glycoside hydrolases are negatively offset by 
typically higher hydrolytic activity.23 To address this, Withers et al. introduced an idea of glycosynthase, 
engineering a glycoside hydrolase to remove a nucleophile residue, and thus making the mutant non-hydrolytic 
while the intact original structure of the mutant allows the formation of the glycosidic bond.55 In an early 
example of glycosynthase Abg E358A made from a glucosidase from Agrobacterium sp., α-glucosyl fluoride 
was used as a donor and 2,4-dinitrophenly β-glucoside as an acceptor (Scheme 25).55 The reaction yielded a 
mixture of β-(14)-linked di- (38%), tri- (42%) and tetrasaccharides (4%). There are also examples that used 
wild type glycoside hydrolases in transglycosidation. α-Glucosyl fluoride and α-galactosyl fluoride were used to 
monitor transglycosidation kinetics of α-glycoside hydrolases including α-glucosidase from Baker’s yeast 
Saccharomyces cerevisiae (Scheme 25) and α-galactosidase from either green coffee beans or Bacillus 
stearothermophilus with 19F NMR.56 These reactions yielded mixtures of anomeric fluorides of mostly α-(12) 
and α-(16) disaccharides.  Field et al. also applied 19F NMR to monitor the transglycosidation activity of three 
GH enzymes, glucanotranferases from E. coli (EcMalQ), Manihot esculenta (MeDPE1) and Arabidopsis 
thaliana (AtDPE2) using 2-fluoro-, 3-fluoro- and 6-fluoro-glucose as an acceptor and glycogen as a donor 
(Scheme 25).57 These GHs are characterised by their high α-(14) transglycosidation activity, thus given their 
name of glucanotransferase. All three fluorinated glucoses acted as an acceptor, yielding mixtures of 
maltooligosaccharides with different lengths in the reaction with the respective enzymes, and the conversion 










UDP-4FGalNAc is accessible from chemically synthesised 4FGalNAc-1P via a recombinant human enzyme, 
UDP-N-acetylglucosamine pyrophosphorylase (GlmU) (Scheme 26).  Using a crude cell extract, an 18% yield 
of UDP-4GalNAc was isolated and structurally characterised after 2 h.58   
 
  
Scheme 26 Enzymatic synthesis of UDP-4FGalNAc and UDP-4FGlcNAc using human UDP-N-
acetylglucosamine pyrophosphorylase (GlmU).58 
 
Fluorinated GalNAc residues were also recognised as acceptor substrates for the phosphorylase enzyme 
BiGalHexNAcP (Scheme 27).  The disaccharide Gal 1-3 6FGalNAc, with the fluorinated sugar moiety at the 
reducing end of the disaccharide can be obtained in milligram scale.  The synthetic yield of 88% is in fact 
slightly higher than that with GalNAc as the acceptor (81%). However the anomeric substituent in the GalNAc 
acceptor is OH and the increased yield may be a result of more facile purification owing to the azidopropyl 









Like UDP-4FGalNAc, UDP-4FGlcNAc can be synthesised by chemoenzymatic methods.  Chemically 
synthesised 4FGlcNAc-1P can be converted enzymatically to UDP-4FGlcNAc using a recombinant human 
enzyme, GlmU (Scheme 26).58 Yields of UDP-4FGlcNAc are slightly better than the galacto-configured isomer 
(23% vs. 18%) over shorter times (1 h vs. 2 h), which is surprising given the natural substrate for the enzyme 
contains Gal rather than Glc stereochemistry. 
Further to this, Amano et al.59 were able to demonstrate the in vivo synthesis of UDP-4FGlcNAc in a human 
cancer cell line (PC-3) from acetylated 4FGlcNAc sugars (the acetylation was required for cellular uptake) via 
hijacking of the cellular hexosamine biosynthetic pathway.  Further studies on cellular metabolic glycans 
revealed that the 4FGlcNAc moiety was not incorporated in glycans produced by the Golgi-N-glycosylation 
pathways and instead UDP-4FGlcNAc acted as an inhibitor of GlcNAc transferases present in the pathway.  
5F-GlcNAc derivatives were initially synthesised to probe whether the introduction of fluorine at the 5-position 
would render such compounds enzyme inhibitors.  Preliminary studies indicated that 5FGlcNAc-1P is a 
substrate for the enzyme GlmU and could be used for the synthesis of UDP-5FGlcNAc (Scheme 28).60  UDP-
5FGlcNAc is however an inhibitor of the enzyme UDP-GlcNAc 4 epimerase 60 and the glycosyltransferases, 
CLS61 and CgMshA.62  
 
Scheme 28 Enzymatic synthesis of UDP-5FGlcNAc using GlmU.60 
  
Conversely, the introduction of the fluorine at C-5 in acceptor substrates is recognised by the 
glycosyltransferases CLS and GalT (bovine milk), which transfer a galactosyl moiety to the 4-position, albeit at 
reduced efficiency when compared with the natural substrate GlcNAc for GalT (Scheme 29).60-61  Kinetic 
parameters suggest the low efficiency is due to a lower affinity of the enzyme for the modified acceptor, 





Scheme 29 Use of 5FGlcNAc as an acceptor of bovine milk β-1,4-galactosyltransferase.60 
 
A different type of fluorination, not directly part of the pyranose ring, but at the N-acetyl group, is possible in D-
GlcNAc. In an early study, it was demonstrated that chemically synthesized UDP-N-trifluoroacetylglucosamine 
(UDP-GlcNTFA) was tolerated fairly well by two glucosaminyltransferases, ‘core-2’ GlcNAc transferase, 
involved in the biosynthesis of O-linked glycoproteins, and UDP-D-GlcpNAc:α-D-Manp-(16)-β-D-GlcpNAc 
transferase V (GlcNAcT-V), a key biosynthetic enzyme controlling the branching pattern of cell surface 
complex Asn-linked oligosaccharides (Scheme 30).63 Both enzymes were able to synthesize trisaccharide 
products with 62% and 56% isolated yield. Later, it was found that UDP-GlcNTFA was an excellent substrate 
for Pasteurella multocida strain P-1059 heparosan synthase 2 (PmHS2), a bifunctional enzyme that acts both as 
























































































Scheme 30 Use of UDP-GlcNTFA as a donor of N-acetylglucosaminyltransferases, Core-2 GlcNAc transferase 
and GlcNAcT-V.63 
 
It was also demonstrated that the acceptor UDP-GlcNTFA could be synthesized enzymatically using 
Bifidobacterium longum ATCC55813 N-acetylhexosamine 1-kinase (NahK) and Pasteurella multocida strain P-
1059 (ATCC15742) N-acetylglucosamine-1-phosphate uridylyltransferase (PmGlmU).64, 66 Along with these 
two enzymes, PmHS2 was used in a one-pot multi-enzyme system for the synthesis of heparan sulfate 
oligosaccharides (Scheme 31). The trifluoroacetyl moiety was then hydrolysed in a mild basic condition, and the 
resulting free amine moiety sulfated either enzymatically or chemically, yielding natural heparan sulfate 
oligosaccharides.67 
 
Scheme 31 One-pot multi-enzyme system for the synthesis of heparin sulfate oligosaccharides containing NahK 
(N-acetylhexosamine 1-kinase), PmGlmU (Pasteurella multocida strain P-1059 (ATCC15742) N-
acetylglucosamine-1-phosphate uridylyltransferase), inorganic pyrophosphatase, and PmHS2 (heparosan 
synthase 2, bifunctional glycosyltransferase).64 
 
7.  Fluorinated Talose 
In addition to tolerating all the four isomers of FGal-1P, GalPUT is also able to process sugars which contain 
the talose stereochemistry (axial at C-2).  Errey and co-workers demonstrated that the immobilised system 
described in section 3.1 is able to synthesise UDP-2FTal from 2FTal in 71% yield (Scheme 32).68 This is greater 
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than for unmodified Tal (15%) and although yields are comparable to Gal and derivatives, longer reaction times 





2-Deoxy-2-fluorinated analogues of sialyl Lewis a can be synthesised in milligram quantities from the donor 
GDP-2F-L-Fuc using the fucosyltransferase (FucT) III enzyme (Scheme 33).69 Extended reaction times (up to 
one day) are needed to achieve a comparable yield (88%) to the natural donor GDP-L-Fuc (97%). However, the 
stereo- and regio-selectivity of the enzyme is not altered by the fluorinated donor. This result is remarkable 
since fluorination at the position adjacent to the anomeric centre normally creates a highly unfavourable 
environment for the glycosyl transfer reaction that involves an oxocarbenium ion-like transition state.70 Usually, 
GDP-2F-L-Fuc has been observed to act as a competitive inhibitor of a number of human fucosyltransferases.8, 
71 In line with this, Fuc-T VI does not accept GDP-2FFuc to synthesise sialyl Lewis x analogues69 although the 
authors did not evaluate the fluorinated analogue as an inhibitor.  
 
Scheme 33 Enzymatic synthesis of sialyl Lewis a containing 2-fluoro-L-fucose.69 
 
GDP-6F-L-Fuc has also been shown to be a competitive inhibitor toward the human fucosyltransferases III, V, 
VI and VII , however the 6F-L-Fuc moiety can be introduced into Lewis x analogues from 6F-L-Fuc making 
use of the bifunctional enzyme L-fucokinase/GDP-fucose pyrophosphorylase (FKP) and the bacterial -(1→3) 
fucosyltransferase (Scheme 34).72 Although FKP has a lower affinity for 6F-L-Fuc than L-Fuc, milligram 
quantities of GDP-6F-L-Fuc can be prepared in 94% yield from 6FFuc in 5-6 hours.  When FKP is combined in 
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a one-pot, two-enzyme reaction with the fucosyltransferase the sialyl Lewis x derivative can be synthesised 
directly from 6F-L-Fuc, without the need to isolate GDP-6F-L-Fuc, in 90% yield.  In both cases, the regio- and 
stereoselectivity of the enzymes was confirmed spectroscopically. 
  
 
Scheme 34 Enzymatic synthesis of Lewis x derivative containing 6-fluoro-L-fucose.72 
 
When combined with the -(1→2) fucosyltransferase FutC, FKP can also append a 6F-L-Fuc moiety to the non-
reducing end of a Gb5 oligosaccharide to yield a derivative of Globo H (Scheme 35).  Although FKP can be 
used to synthesise GDP-gem-6FF-Fuc from gem-6FF-Fuc, the former is not a good substrate for FutC, with 





Scheme 35 One-pot multi-enzyme system for the synthesis of fluorinated derivative of Globo-H.73 FKP = L-




Some fluorinated sialic acid donors have been shown to inhibit SiaTs or TcTS, whilst others have been shown to 
act as substrates for sialic acid processing enzymes, many of which are discussed in the following section.  
 
9.1   3‐Fluorinated sialic acids  
Watts and Withers demonstrated that CMP-3FaxNeu5Ac could be synthesised in 91% yield from 3FaxNeu5Ac 
and CTP using CMP-sialic acid synthase (CSS).  To effect this transformation, the authors used a sialic acid 
aldolase (Scheme 36).74 In this synthesis sialic acid aldolase catalyses the formation of Neu5Ac from ManNAc 
and pyruvate.75  By using fluoropyruvate in place of pyruvate, 3FaxNeu5Ac was successfully synthesised. When 
the two enzyme reactions were coupled together, CMP-3FaxNeu5Ac was isolated in 84% yield over 2 steps from 






Chen et al.76 later demonstrated that when the condensation was carried out with a recombinant aldolase from E. 
coli a mixture of both 3F axial and equatorial isomers were formed.  These isomers could be which readily 
separated by flash chromatography and isolated in in 52 and 44% yield, respectively.  Axial and equatorial 
isomers of 3-fluoro-N-glycolylneuraminic acid (3FNeu5Gc) and 3-fluoro-keto-deoxynonulosonic acid (3FKDN) 
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were also formed from the aldolase promoted condensation of 3-fluoropyruvate and N-glycolylmannosamine 
(ManNGc) or Man respectively.  
 
Despite early claims that neither 3FeqNeu5Ac nor 3FaxNeu5Ac are substrates for CSS from calf brain 77,78, Chen 
and colleagues went on to demonstrate the both 3FaxNeu5Ac and 3FeqNeu5Ac were substrates for CSS from 
Neisseria meningitides (NmCSS), and the CMP-sialic acids could be synthesised in excellent yields (Scheme 
37)76. Furthermore, Heise et al. reported that a C-5 carbamate increases the efficiency of the conversion of 3F 




The presence of the electronegative fluorine atom adjacent to the anomeric carbon has meant that CMP-
3FaxNeuAc has been utilised as an inhibitor of a commercial -(2→6) SiaT,78 the SiaT Cst-II from 
Campylobacter jejuni80 and TcTs.81  Nevertheless, Chen et al. demonstrated that CMP-3FaxNeu5Ac and CMP-
3FaxNeu5Gc are substrates for the -(2→3) SiaT from Pasteurella multocida (PmST1). Fluorinated sialyl 
lactosides can be prepared in a one-pot, two-enzyme (NmCSS and PmST1) system from the corresponding 3Fax 
sialic acid (Scheme 38).  Under the same conditions, the sialyl lactosides containing the 3Feq sialic acid could be 
obtained in higher yields.  The -(2→6) SiaT from Photobacterium damselae (Pd2,6ST) does not appear to 
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tolerate the fluorinated donors as well as PmST1 can, and corresponding yields of the 2-6 fluorosialyl 



























































































Wong et al.82 reported the synthesis of 5-fluorinated 5-epi KDN in 30% yield from 2-deoxy-2-fluoroglucose 
(2FGlc) and pyruvate using a sialic acid aldolase (Scheme 39). However, microbial CSS did not recognise 5F, 
5-epi KDN as a substrate, possibly due to either the lack of 5-NHAc, or the differing stereochemistry (axial) at 
C-5 compared with Neu5Ac or KDN (equatorial). 
 
Scheme 39 The enzymatic synthesis of 5, 5‐epi FKDN from 2FGlc.82 
More recently, Chen et al.83 reported the enzymatic synthesis of 5FKDN from 2-deoxy-2-fluoromannose 
(2FMan) using a sialic acid aldolase from Pasteurella multocida (Pm sialic acid aldolase). The authors utilised 
this transformation in a one-pot, three-enzyme system which also contained NmCSS and either PmST1 or 
Pd2,6ST with a para-nitrophenyl galactoside (GalβpNP) acceptor to give either the α2-3 or α2-6 fluorinated 
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disaccharide in yields of 74% and 79% respectively (Scheme 40). Despite these good yields, they were not as 
high as for the analogous reactions containing Neu5Gc derivatives.  
 
Scheme 40 The one-pot, three-enzyme synthesis of 5FKDN-containing disaccharides.83 
 
9.3   7‐Deoxy‐7‐fluoro sialic acids 
The enzymatic synthesis of CMP-7FNeu5Ac from the corresponding 4FManNAc using sialic acid aldolase and 
CSS was initially explored by Dräger et al.84  Using conditions which had resulted in full conversion of 
ManNAc to Neu5Ac, only 56% conversion to 7FNeu5Ac was obtained from 4FManNAc using a commercially 
available aldolase enzyme (Scheme 41). In order to shift the equilibrium of the aldolase catalysed reaction 
toward the sialic acid, coupling with the CSS from Neisseria meningitidis serogroup B (NmBCSS) was 
explored. This approach, however, did not significantly improve conversion to CMP-7FNeuAc as determined 
by LC-ESI-MS and both 4FManNAc and 7FNeu5Ac remained.  Full conversion to CMP-7FNeuAc was only 
achieved when isolated 7FNeu5Ac was turned over by NmBCSS in the presence of pyrophosphatase.  It is 
worthy to note that the authors investigated other sources of CSS (murine CSS or rainbow trout CMP-Kdn-
synthetase), however best results were obtained with NmBCSS. 
 
Scheme 41 The enzymatic synthesis of CMP-7FNeu5Ac.84 
 
Preparative scale synthesis of sialosides containing the 7FNeu5Ac from hexoses via a one-pot, three-enzyme 
system was later demonstrated by Khedri et al.85  Using GalβpNP as an acceptor and employing Pm sialic acid 
aldolase, NmCSS and either PmST1 or Pd2,6ST, milligram scale synthesis of the galactosyl -(2→3) or -
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(2→6) sialosides could be isolated and fully characterised in 98 and 92% yields respectively (Scheme 42). 
Using the same enzymes, the -(2→3) and -(2→6) 7FKDN disaccharides could also be synthesised from 
4FMan in 98 and 95% yields respectively. In both cases, isolation of the sialic acid or CMP-sialic acid was not 





CMP-8FNeu5Ac can be isolated in 82% yield from 8FNeu5Ac after 6 hours reaction with NmCSS and an 
inorganic pyrophosphatase (Scheme 43).  Kinetic studies revealed that the -(2→3) SiaT from Campylobacter 
jejuni (Cst-I) is able to transfer CMP-8FNeu5Ac to modified lactose acceptors (60 minutes), albeit with less 
efficiency than the natural donor CMP-Neu5Ac (2 minutes).  Nonetheless, a sialyl lactose derivative could still 
be isolated in milligram quantities and 80% yield using this enzyme.  Spectroscopic analysis confirmed the 
regio- and stereoselectivity of the enzyme was retained with the fluorinated donor.  Under conditions optimal 
for -(2→3) -sialyltransfer activity, the multifunctional enzyme Pm0188h (Pasteurella multocida) is also able 
to transfer CMP-8FNeu5Ac to a modified lactose acceptor, but unlike Cst-I the reaction does not proceed to 
completion, possibly due to hydrolysis of the sialylated product.86 Indeed, the authors acknowledge Pm0188h 








Early analytical studies suggested that chemically synthesised 9F-Neu5Ac was a substrate for CSS from calf 
brains, albeit kinetics showed the enzyme displayed a lower affinity toward the fluorinated substrate compared 
for the natural substrate Neu5Ac.77, 88  
 
9F-Neu5Ac has been synthesised enzymatically from 6FManNAc, and 14C-radio-labelling was introduced at the 
2-position by Conradt et al. via the coupling of 6FManNAc and [2-14C]pyruvic acid using the enzyme 
acylneuraminate pyruvate-lyase  from Clostridium perfringens with an overall yield of 60% (Scheme 44).  
Although kinetic analysis revealed a higher Km for 9F[2-14C]Neu5Ac than that of the natural substrate Neu5Ac, 
activation of the fluorinated substrate with CSS from rat liver gave CMP-9F [2-14C]Neu5Ac in 30% yield after 
purification.  The authors went on to demonstrate CMP-9F [2-14C]Neu5Ac is a substrate for an -(2→6) SiaT 
from rat liver, and can be transferred onto a galactosyl terminated asialo-1-acid glycoprotein acceptor, albeit at 







Liu et al.82 have also demonstrated the synthesis of 9-deoxy-9-fluorinated sialic acid derivatives of Neu5Ac and 
KDN from modified hexopyranose derivatives and pyruvate using sialic acid aldolase (Scheme 45).  Kinetic 
studies revealed that CSS enzymes from E. coli (both a tagged and native enzyme) were able to turnover 
9FNeu5Ac with parameters similar to those for the natural substrate Neu5Ac.  Conversely, the 7F, 9F di-
fluorinated 7-epi KDN derivative was not recognised by the enzyme, however the authors postulate this 
























































Using the same one-pot, three-enzyme system described for the synthesis of 7-fluorinated -(2→3) or -(2→6) 
sialosides, Khedri et al. extended the substrate scope to include 6FManNAc, 6FManNGc and 6FMan derivatives 
(Scheme 46).  Yields of the corresponding sialosides were >95% in all cases, which is comparable or better than 






Kajihara et al. presented a strategy to introduce 13-C labelling at the C-3 of modified Neu5Ac residues, taking 
advantage of the established synthetic routes used to obtain fluorinated Neu5Ac derivatives from Neu5Ac using 
selective protection and deprotection.  This avoided the synthesis of the fluorinated ManNAc analogues, of 
which the authors argue the synthetic chemistry of which has been less explored.  Thus, two aldolase reactions 
were performed, the first, coupled with pyruvate removal by lactate dehydrogenase, promoted the degradation 
of the fluorinated Neu5Ac derivative to the hexose (Scheme 47).  After conversion to the hexose and switching 
off of the cofactor regeneration cycle, the second aldose reaction with labelled pyruvate resulted in the labelled 
Neu5Ac analogue.  Using this two-step, one-pot reaction, 9F[3-13C]Neu5Ac was synthesised in milligram scales 
(62% yield) with 96% 13C labelling incorporated.91  Subsequent chemical conversion of 9F [3-13C]Neu5Ac into 















































Glycosylation of fluorinated sugars using enzymatic methods has been achieved for a wide range of 
monofluorinated sugars and has been employed in the synthesis of many fluorinated oligosaccharides. 
Monofluorinated monosaccharides including galactose, glucose and sialic acid have been successfully utilised 
as donors and acceptors for glycosylation, for the production of a diverse range of fluorinated disaccharide and 
trisaccharide targets, and phosphorylated di- and tetrafluorinated galactose donors have been enzymatically 
synthesised, although not yet successfully used in enzymatic glycosylations. The incorporation of more heavily 
fluorinated monosaccharides into glycans through glycosylation remains challenging by enzymatic means, 
however enzymatic glycosylations to date have relied mainly on the use of natural enzymes, and the future 
development of engineered enzymes able to accept a wider range of unnatural substrates could provide new 
routes to glycans with more complicated fluorination patterns. Enzyme reaction rates using fluorinated sugars 
are often low in comparison to the natural substrates, but it has been demonstrated that where an unnatural sugar 
is able to be accepted by the enzyme, even sugars initially considered competitive inhibitors of the enzyme can 
be enzymatically transformed with careful optimisation of reaction conditions. One limitation of enzymatic 
synthesis is the low commercial availability of glyco-enzymes, with enzyme supply often reliant on transfers of 
enzymes, plasmids or expressed cells between researchers and in-house enzyme production, which restricts the 
uptake of these methods by chemists, who may choose a more familiar chemical glycosylation route over an 
enzymatic route that requires production of the specific enzyme for the transformation. The next generation of 
fluorinated glycans are likely to require a combination of chemical and enzymatic transformations to achieve 
more diverse fluorination patterns. 
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